Torthaí cuardaigh - Modupe Idowu
- 1 - 6 toradh as 6 á dtaispeáint
-
1
Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity de réir Kaiqi Sun, Yujin Zhang, Mikhail Bogdanov, Hongyu Wu, Anren Song, Jessica Li, William Dowhan, Modupe Idowu, Harinder S. Juneja, Jose G. Molina, Michael R. Blackburn, Rodney E. Kellems, Yang Xia
Foilsithe / Cruthaithe 2015Artigo -
2
Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease de réir Santosh L. Saraf, Robert Hagar, Modupe Idowu, Ifeyinwa Osunkwo, Kimberly Cruz, Frans A. Kuypers, R. Clark Brown, James Geib, Maria Ribadeneira, Patricia Schroeder, Eric Wu, Sanjeev Forsyth, Patrick Kelly, Theodosia A. Kalfa, Marilyn J. Telen
Foilsithe / Cruthaithe 2024Artigo -
3
Hypoxia-mediated impaired erythrocyte Lands’ Cycle is pathogenic for sickle cell disease de réir Hongyu Wu, Mikhail Bogdanov, Yujin Zhang, Kaiqi Sun, Shushan Zhao, Anren Song, Renna Luo, Nicholas Parchim, Hong Liu, Aji Huang, Morayo G. Adebiyi, Jianping Jin, Danny C. Alexander, Michael V. Milburn, Modupe Idowu, Harinder S. Juneja, Rodney E. Kellems, William Dowhan, Yang Xia
Foilsithe / Cruthaithe 2016Artigo -
4
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results de réir Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse L. C. Lobo, Swee Lay Thein, Biree Andemariam, Obiageli Nnodu, Adlette Inati, Alexander Glaros, Sara Teresinha Olalla Saad, Pablo Bartolucci, Raffaella Colombatti, Alì Taher, Miguel R. Abboud, Abdulafeez Oluyadi, Varsha Iyer, Ophelia Yin, Susan Morris, Amber M. Yates, Hui Shao, Spurthi Patil, Rolandas Urbstonaitis, Ahmar U. Zaidi, Wally R. Smith
Foilsithe / Cruthaithe 2023Artigo -
5
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression de réir Yujin Zhang, Vladimír Berka, Anren Song, Kaiqi Sun, Wei Wang, Weiru Zhang, Ning Chen, Chonghua Li, Qibo Zhang, Mikhail Bogdanov, Danny C. Alexander, Michael V. Milburn, Mostafa H. Ahmed, Lin Han, Modupe Idowu, Jun Zhang, Gregory J. Kato, Osheiza Abdulmalik, Wenzheng Zhang, William Dowhan, Rodney E. Kellems, Pumin Zhang, Jianping Jin, Martin K. Safo, Ah‐Lim Tsai, Harinder S. Juneja, Yang Xia
Foilsithe / Cruthaithe 2014Artigo -
6
Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease de réir Kaiqi Sun, Angelo D’Alessandro, Mostafa H. Ahmed, Yujin Zhang, Anren Song, Tzu‐Ping Ko, Travis Nemkov, Julie A. Reisz, Hongyu Wu, Morayo G. Adebiyi, Zhangzhe Peng, Jing Gong, Hong Liu, Aji Huang, Y. Edward Wen, Alexander Wen, Vladimír Berka, Mikhail Bogdanov, Osheiza Abdulmalik, Leng Han, Ah‐Lim Tsai, Modupe Idowu, Harinder S. Juneja, Rodney E. Kellems, William Dowhan, Kirk C. Hansen, Martin K. Safo, Yang Xia
Foilsithe / Cruthaithe 2017Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Medicine
Disease
Internal medicine
Cell biology
Chemistry
Receptor
Sphingosine
Biochemistry
Endocrinology
Genetics
Immunology
Pathology
Randomized controlled trial
Sphingosine kinase 1
Sphingosine-1-phosphate
Acute chest syndrome
Adenosine
Adenosine A2A receptor
Adenosine A2B receptor
Adenosine A3 receptor
Adenosine receptor
Adverse effect
Agonist
Alternative medicine
Antagonist
Bioinformatics
Biophysics
Cell
Clinical endpoint